An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.

Medical devices range from something as simple as an elastic bandage to something as complicated as a deep-brain stimulator. This review describes the FDA approach for understanding and approving medical devices.

[1]  W. Sapirstein,et al.  FDA's requirements for in-vivo performance data for prosthetic heart valves. , 1994, The Journal of heart valve disease.

[2]  Tamara Syrek Jensen,et al.  Transcatheter valve therapy registry is a model for medical device innovation and surveillance. , 2015, Health affairs.

[3]  B. Frémont,et al.  SUMMARY OF SAFETY AND EFFECTIVENESS DATA , 2002 .

[4]  M. Link,et al.  2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Heart rhythm.

[5]  Ron Kalin,et al.  Current Clinical Issues for MRI Scanning of Pacemaker and Defibrillator Patients , 2005, Pacing and clinical electrophysiology : PACE.

[6]  M. Mack,et al.  Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2015, JACC. Cardiovascular interventions.

[7]  R. Califf.  A new look at an old therapy. , 2012, JAMA.

[8]  Robert M Califf,et al.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. , 2012, JAMA.

[9]  S. Ikramuddin,et al.  The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[10]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[11]  Carol Rados.  Medical device and radiological health regulations come of age. , 2006, FDA consumer.